Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: John B. Porter Maria Domenica Cappellini Dudley Pennell Ali Taher |
| Publication date | January 22, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |